TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6140167

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-AS) 0.5 g suppositories
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sulphasalazine (SZ) 1 g tid (equivalent to 5-AS 1.14 g/day)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Oral slow-release form of 5-AS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 5-AS and AcAS
Number of subjects: 15
Study: 31360062

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000 IU once a week for 8 weeks, then once a month for 4 months)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 28968171

Group type: EXPERIMENTAL
Intervention: Naldemedine 0.2 mg
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 25720723

Group type: EXPERIMENTAL
Intervention: Flavonoids (Group A)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (Group B)
Number of subjects: 59
Study: 23203345

Group type: EXPERIMENTAL
Intervention: Negative visual conditioning stimuli (pictures)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Neutral visual conditioning stimuli (pictures)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Positive visual conditioning stimuli (pictures)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Sweet gustatory stimuli (gelatine)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Bitter gustatory stimuli (gelatine)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Thermal stimuli (control experiment)
Number of subjects: 31
Study: 21632737

Group type: EXPERIMENTAL
Intervention: Online coaching support from a certified peer specialist
Number of subjects: 118

Group type: COMPARATOR
Intervention: No online coaching support (Control)
Number of subjects: 118
Study: 19336559

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 388

Group type: COMPARATOR
Intervention: Control (no folic acid supplementation)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Right colon
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Left colon
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: LINE-1 methylation
Number of subjects: 388
Study: 16923481

Group type: EXPERIMENTAL
Intervention: Active patch (GTN)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 318
Study: 15504999

Group type: EXPERIMENTAL
Intervention: Enhanced therapy (handheld infrared skin thermometer, measuring temperatures on the sole of the foot in the morning and evening)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard therapy (therapeutic footwear, diabetic foot education, regular foot evaluation by a podiatrist)
Number of subjects: 85
Study: 12243704

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing (HCD) over clobetasol propionate 0.05% lotion once a week
Number of subjects: 61

Group type: COMPARATOR
Intervention: Clobetasol propionate ointment used unoccluded twice a day
Number of subjects: 61
Study: 8327414

Group type: EXPERIMENTAL
Intervention: Intensive behavioral program for smoking cessation
Number of subjects: 3923

Group type: COMPARATOR
Intervention: Aerosol inhaler (active bronchodilator or placebo)
Number of subjects: 3923

Group type: EXPERIMENTAL
Intervention: Nicotine gum as an adjunct to the behavioral program
Number of subjects: 3923
Study: 3526421

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Domperidone
Number of subjects: 0
Study: 31021112

Group type: EXPERIMENTAL
Intervention: Participants who purchased items for others (intervention group)
Number of subjects: 437

Group type: COMPARATOR
Intervention: Participants who purchased items for themselves (control group)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Individual differences in OXTR single nucleotide polymorphisms (rs53576, rs2268498, rs2254298)
Number of subjects: 437
Study: 29175065

Group type: EXPERIMENTAL
Intervention: Luteal phase support starting 1 day after oocyte retrieval (group A)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Luteal phase support on the day of oocyte retrieval (group B)
Number of subjects: 233
Study: 27099249

Group type: COMPARATOR
Intervention: Mediterranean diet (MedDiet) interventions
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: Baseline short- and medium-chain acylcarnitines
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: Increased short-chain acylcarnitines after 1 year
Number of subjects: 751
Study: 24468997

Group type: EXPERIMENTAL
Intervention: Home-based care delivered by trained lay workers
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Clinic-based care
Number of subjects: 1453
Study: 21951265

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 20679146

Group type: EXPERIMENTAL
Intervention: Barley beta-glucan-enriched biscuits (BB), 628 kJ preload
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control biscuits (CB), 628 kJ preload
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Barley beta-glucan-enriched biscuits (BB), 1884 kJ preload
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control biscuits (CB), 1884 kJ preload
Number of subjects: 20
Study: 19374071

Group type: EXPERIMENTAL
Intervention: African potato (AP) decoction administered daily from day 16 to day 30
Number of subjects: 10
Study: 15754421

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 31

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 12719963

Group type: EXPERIMENTAL
Intervention: Nutritionally-sourced tryptophan (1.8 g)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10320169

Group type: EXPERIMENTAL
Intervention: Midazolam (0.04 mg/kg) IV
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo IV
Number of subjects: 30
Study: 8943160

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 584

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 584
Study: 1285937

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 2859792

Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (similar patients not receiving exercise intervention)
Number of subjects: 59
Study: 29742525

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 700
Study: 29668535

Group type: EXPERIMENTAL
Intervention: Monthly high-dose oral cholecalciferol over 2 years
Number of subjects: 4
Study: 27567760

Group type: EXPERIMENTAL
Intervention: Focal Vibrations (FV)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 20
Study: 25320235

Group type: EXPERIMENTAL
Intervention: Pharmacological inhibition of PCSK9
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCSK9 loss-of-function genetic variants
Number of subjects: 0

Group type: COMPARATOR
Intervention: LPS administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: PCSK9 function
Number of subjects: 0
Study: 22782510

Group type: EXPERIMENTAL
Intervention: ADNI
Number of subjects: 0

Group type: COMPARATOR
Intervention: MCSA
Number of subjects: 0
Study: 20171404

Group type: COMPARATOR
Intervention: Placebo effects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo effects in clinical practice
Number of subjects: 0
Study: 18330460

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT), 8 sessions
Number of subjects: 39
Study: 15839956

Group type: EXPERIMENTAL
Intervention: Paclitaxel-platinum combination therapy
Number of subjects: 802

Group type: COMPARATOR
Intervention: Conventional platinum-based therapy
Number of subjects: 802
Study: 12209102

Group type: EXPERIMENTAL
Intervention: Active treatment with HDM-impermeable encasings for mattresses, pillows, and duvets for 12 months.
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo treatment with cotton encasings for mattresses, pillows, and duvets for 12 months.
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Both groups (active and placebo)
Number of subjects: 86
Study: 10496190

Group type: EXPERIMENTAL
Intervention: Hydralazine plus isosorbide dinitrate (H‐I) in black patients
Number of subjects: 180

Group type: COMPARATOR
Intervention: Enalapril therapy in white patients
Number of subjects: 180

Group type: COMPARATOR
Intervention: Enalapril therapy in white patients with a history of hypertension
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo group in V‐HeFT I
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Hospitalization rates
Number of subjects: 180
Study: 9191512

Group type: EXPERIMENTAL
Intervention: Perindopril 2 mg
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Perindopril 8 mg
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Perindopril 16 mg
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study: 1511219

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CT
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Angiography
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MRI and CT combined
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MR-angiography
Number of subjects: 30
Study: 6587296

Group type: EXPERIMENTAL
Intervention: Zomepirac sodium 100 mg
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Fenoprofen calcium 200 mg
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 30882751

Group type: EXPERIMENTAL
Intervention: Single dose of 1 × 200 mg elemental iron (SINGLE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Split dose of 2 × 100 mg elemental iron (SPLIT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 30300426

Group type: EXPERIMENTAL
Intervention: 3% saline
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 40
Study: 27553102

Group type: EXPERIMENTAL
Intervention: Right bundle branch block (RBBB)
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: Left bundle branch block (LBBB)
Number of subjects: 682

Group type: COMPARATOR
Intervention: No bundle branch block (no-BBB)
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: RBBB
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: LBBB
Number of subjects: 682
Study: 25272316

Group type: EXPERIMENTAL
Intervention: Early goal-directed therapy (EGDT)
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1600
Study: 22712470

Group type: EXPERIMENTAL
Intervention: Tretinoin microsphere gel 0.04% pump
Number of subjects: 110

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 110
Study: 20096223

Group type: EXPERIMENTAL
Intervention: TIVA with remifentanil
Number of subjects: 70

Group type: COMPARATOR
Intervention: Balanced anesthesia (BA) with esmolol
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: TIVA with remifentanil and BA with esmolol
Number of subjects: 70
Study: 17636093

Group type: EXPERIMENTAL
Intervention: Moderate exercise with bright light treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Moderate exercise without bright light treatment
Number of subjects: 25
Study: 16118756

Group type: EXPERIMENTAL
Intervention: Hip head-conserving therapy with two cranial screws and a three-point-supported screw at Adam's arc
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional osteosynthesis
Number of subjects: 0
Study: 11900101

Group type: EXPERIMENTAL
Intervention: Geometric prototypes located at the centers of left and right categories
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subsets of targets positioned at different locations within each category
Number of subjects: 0
Study: 10084466

Group type: EXPERIMENTAL
Intervention: Budesonide turbuhaler, 1,600 microg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: COMPARATOR
Intervention: Formoterol + Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Formoterol + Budesonide
Number of subjects: 10
Study: 7567130

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1,000 mg intravenously 30 min before anesthesia
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1,000 mg intravenously before anesthesia and a second 1,000 mg dose at the initiation of cardiopulmonary bypass
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (1,000 mg and 2,000 mg regimens)
Number of subjects: 20
Study: 2127604

Group type: EXPERIMENTAL
Intervention: hMG treatment with short-term GnRH agonist (Buserelin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment with hMG alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: hMG treatment started shortly after LH rise caused by GnRH agonist
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: hMG treatment commenced when hypogonadotropic state achieved after long treatment of Buserelin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (hMG with and without GnRH agonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-term group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term group
Number of subjects: 0
Study: 7114867

Group type: EXPERIMENTAL
Intervention: Partial stripping of the stratum corneum
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 159
Study: 31802616

Group type: EXPERIMENTAL
Intervention: Sitagliptin (SITA) 100 mg qd
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Metformin (MET) 850 mg bid
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Metformin + Sitagliptin (MET+SITA) 50 + 850 mg bid
Number of subjects: 40
Study: 31471037

Group type: EXPERIMENTAL
Intervention: Losartan (LT) 50 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 29948456

Group type: EXPERIMENTAL
Intervention: Combined 660- and 808-nm wavelengths low-level laser therapy (LLLT) (300 J/cm2, 9 J of total energy, 100 mW, spot size 3 mm2), performed twice a week.
Number of subjects: 0

Group type: COMPARATOR
Intervention: 660-nm wavelength low-level laser therapy (LLLT) (300 J/cm2, 9 J of total energy, 100 mW, spot size 3 mm2), performed twice a week.
Number of subjects: 0
Study: 26373826

Group type: EXPERIMENTAL
Intervention: Pleth Variability Index (PVI)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Doppler
Number of subjects: 75
Study: 25187257

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (vitamin C) 10 mg/kg/day and α-tocopherol (vitamin E) 10 mg/kg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ascorbic acid and α-tocopherol
Number of subjects: 0
Study: 22342027

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral self-help program (SHP) combined with pharmacotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pharmacotherapy alone (control)
Number of subjects: 80
Study: 20228402

Group type: EXPERIMENTAL
Intervention: Nateglinide (up to 60 mg three times daily)
Number of subjects: 9306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9306
Study: 17491259

Group type: EXPERIMENTAL
Intervention: FASL‐844 TT genotype
Number of subjects: 184

Group type: COMPARATOR
Intervention: FASL‐844 CT and TT genotypes
Number of subjects: 184
Study: 15797672

Group type: EXPERIMENTAL
Intervention: Calcium pyruvate (PYR) 5 g twice daily for 30 days
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 23
Study: 11965274

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy screening
Number of subjects: 170432

Group type: COMPARATOR
Intervention: Control group (not contacted)
Number of subjects: 170432
Study: 9927844

Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thrombolytic therapy (t-PA)
Number of subjects: 0
Study: 8713941

Group type: EXPERIMENTAL
Intervention: Colgate Total toothpaste
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Colgate Tartar Control toothpaste
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Pepsodent Ultra toothpaste
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 143
Study: 2669554

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 400 micrograms
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 1000 micrograms
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (BUD) 400 micrograms
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (BUD) 800 micrograms
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 128
Study: 365774

Group type: EXPERIMENTAL
Intervention: High dose subunit vaccine (2100 IU)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Whole virus vaccine (2100 IU)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Low dose subunit vaccine (700 IU)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Split virus adjuvant vaccine (800 IU with AI(OH)3)
Number of subjects: 399
Study: 30580896

Group type: EXPERIMENTAL
Intervention: Stereoscopic 3D immersive video exposure-based treatment (six 5-minute exposures)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Psychoeducation only control condition (30-minute neutral video, 2D documentary)
Number of subjects: 77
Study: 28528565

Group type: EXPERIMENTAL
Intervention: Energy Conservation Management (ECM) intervention
Number of subjects: 86

Group type: COMPARATOR
Intervention: Information-only control group
Number of subjects: 86
Study: 26037907

Group type: EXPERIMENTAL
Intervention: Titanium tacks
Number of subjects: 220

Group type: COMPARATOR
Intervention: Absorbable tacks
Number of subjects: 220
Study: 23696200

Group type: EXPERIMENTAL
Intervention: Compassion training
Number of subjects: 0
Study: 21652734

Group type: EXPERIMENTAL
Intervention: OROS-methylphenidate (OROS-MPH)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 19225061

Group type: EXPERIMENTAL
Intervention: Supplemental live reactive telephone counseling (n = 494)
Number of subjects: 990

Group type: COMPARATOR
Intervention: Mailed self-help literature (n = 496)
Number of subjects: 990
Study: 16455419

Group type: EXPERIMENTAL
Intervention: Ultrasound contrast agent (UCA) Optison
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Contrast agents (Optison, Sonovue, Sonazoid)
Number of subjects: 12
Study: 15762255

Group type: EXPERIMENTAL
Intervention: Charnley prosthesis
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Lubinus IP
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Other cemented implants
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Uncemented stems
Number of subjects: 129
Study: 11775045

Group type: EXPERIMENTAL
Intervention: Paroxetine (20-50 mg/day)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study: 9400355

Group type: EXPERIMENTAL
Intervention: Total quality improvement methods
Number of subjects: 17324
Study: 8214276

Group type: EXPERIMENTAL
Intervention: mefloquine treatment
Number of subjects: 224
Study: 3593451

Group type: EXPERIMENTAL
Intervention: Terguride (2 X 0.2 mg/d per os)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 28635526

Group type: EXPERIMENTAL
Intervention: Individualized counseling on diet, physical activity, and weight management from trained nurses at six timepoints and three meetings with a dietitian
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Individualized counseling on diet, physical activity, and weight management
Number of subjects: 266
Study: 27206567

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg QD
Number of subjects: 1438

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg BID
Number of subjects: 1438

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1438

Group type: EXPERIMENTAL
Intervention: Lorcaserin and prohibited serotonergic agents
Number of subjects: 1438

Group type: COMPARATOR
Intervention: Placebo and prohibited serotonergic agents
Number of subjects: 1438
Study: 24655769

Group type: EXPERIMENTAL
Intervention: Group-based counselling intervention for depression adapted from Interpersonal Therapy (IPT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Group-based counselling intervention for depression
Number of subjects: 34
Study: 23291605

Group type: EXPERIMENTAL
Intervention: PrT with dextrose
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: PrT with dextrose-morrhuate sodium
Number of subjects: 26

Group type: COMPARATOR
Intervention: Wait-and-see
Number of subjects: 26
Study: 19730952

Group type: EXPERIMENTAL
Intervention: Single-dose Stretta (Group A)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Double-dose Stretta (Group C)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham procedure (Group B)
Number of subjects: 36
Study: 18762804

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Enhanced Usual Care (DSE)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Spouse weight loss
Number of subjects: 357
Study: 17116917

Group type: EXPERIMENTAL
Intervention: Structured multicomponent intervention addressing caregiver depression, burden, self-care, and social support through 12 in-home and telephone sessions over 6 months.
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Structured multicomponent intervention
Number of subjects: 642

Group type: COMPARATOR
Intervention: Control group receiving 2 brief 'check-in' telephone calls during the 6-month intervention.
Number of subjects: 642
Study: 14648126

Group type: EXPERIMENTAL
Intervention: Delta20% priming exercise
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Delta40% priming exercise
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Delta60% priming exercise
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sub-lactate threshold (LT) at 80% of LT
Number of subjects: 8

Group type: COMPARATOR
Intervention: No warm-up control (CON)
Number of subjects: 8
Study: 11710785

Group type: EXPERIMENTAL
Intervention: Cilnidipine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 61